{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T07:34:22Z","timestamp":1778571262899,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.phrs.2017.04.006","type":"journal-article","created":{"date-parts":[[2017,4,8]],"date-time":"2017-04-08T01:01:49Z","timestamp":1491613309000},"page":"242-251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["YM155 induces apoptosis through proteasome-dependent degradation of MCL-1 in primary effusion lymphoma"],"prefix":"10.1016","volume":"120","author":[{"given":"Yuki","family":"Kojima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumihiko","family":"Hayakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanobu","family":"Morishita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiki","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Minamikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mizuho","family":"Iwase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyuki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiki","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Imoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyuki","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Kiyoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.phrs.2017.04.006_bib0005","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1182\/blood.V73.3.792.bloodjournal733792","article-title":"Molecular genetic analysis of three AIDS-associated neoplasms of uncertain lineage demonstrates their B-cell derivation and the possible pathogenetic role of the Epstein-Barr virus","volume":"73","author":"Knowles","year":"1989","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.phrs.2017.04.006_bib0010","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/ajcp\/94.2.170","article-title":"Diagnosis of malignant lymphoma in effusions from patients with AIDS by gene rearrangement","volume":"94","author":"Walts","year":"1990","journal-title":"Am. J. Clin. Pathol."},{"issue":"21","key":"10.1016\/j.phrs.2017.04.006_bib0015","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1200\/JCO.2003.06.013","article-title":"Clinical features and outcome of primary effusion lymphoma in HIV-infected patients: a single-institution study","volume":"21","author":"Simonelli","year":"2003","journal-title":"J. Clin. Oncol."},{"issue":"18","key":"10.1016\/j.phrs.2017.04.006_bib0020","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM199505043321802","article-title":"Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas","volume":"332","author":"Cesarman","year":"1995","journal-title":"N. Engl. J. Med."},{"issue":"5192","key":"10.1016\/j.phrs.2017.04.006_bib0025","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1126\/science.7997879","article-title":"Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi\u2019s sarcoma","volume":"266","author":"Chang","year":"1994","journal-title":"Science"},{"issue":"19","key":"10.1016\/j.phrs.2017.04.006_bib0030","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.1200\/JCO.2005.07.084","article-title":"Prognostic factors and outcome of human herpesvirus 8-associated primary effusion lymphoma in patients with AIDS","volume":"23","author":"Boulanger","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.phrs.2017.04.006_bib0035","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1016\/j.ejca.2014.03.004","article-title":"Efficacy of anti-CD47 antibody-mediated phagocytosis with macrophages against primary effusion lymphoma","volume":"50","author":"Goto","year":"2014","journal-title":"Eur. J. Cancer"},{"issue":"5","key":"10.1016\/j.phrs.2017.04.006_bib0040","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/s12185-013-1339-3","article-title":"Establishment of a CD4-positive cell line from an AIDS-related primary effusion lymphoma","volume":"97","author":"Goto","year":"2013","journal-title":"Int. J. Hematol."},{"issue":"4","key":"10.1016\/j.phrs.2017.04.006_bib0045","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1349-7006.2012.02212.x","article-title":"Antitumor effect of berberine against primary effusion lymphoma via inhibition of NF-kappaB pathway","volume":"103","author":"Goto","year":"2012","journal-title":"Cancer Sci."},{"issue":"10","key":"10.1016\/j.phrs.2017.04.006_bib0050","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s10495-016-1277-7","article-title":"Inhibition of autophagy by chloroquine induces apoptosis in primary effusion lymphoma in vitro and in vivo through induction of endoplasmic reticulum stress","volume":"21","author":"Masud Alam","year":"2016","journal-title":"Apoptosis"},{"issue":"19","key":"10.1016\/j.phrs.2017.04.006_bib0055","doi-asserted-by":"crossref","first-page":"5160","DOI":"10.1158\/1078-0432.CCR-12-2408","article-title":"The promise of patient-derived xenografts: the best laid plans of mice and men","volume":"18","author":"Kopetz","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"13054","key":"10.1016\/j.phrs.2017.04.006_bib0060","article-title":"Discovery of a drug targeting microenvironmental support for lymphoma cells by screening using patient-derived xenograft cells","volume":"5","author":"Sugimoto","year":"2015","journal-title":"Sci. Rep."},{"issue":"35","key":"10.1016\/j.phrs.2017.04.006_bib0065","doi-asserted-by":"crossref","first-page":"56241","DOI":"10.18632\/oncotarget.11025","article-title":"The photosensitizer verteporfin has light-independent anti-leukemic activity for Ph-positive acute lymphoblastic leukemia and synergistically works with dasatinib","volume":"7","author":"Morishita","year":"2016","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.phrs.2017.04.006_bib0070","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1084\/jem.20040254","article-title":"Lymph node fibroblastic reticular cells construct the stromal reticulum via contact with lymphocytes","volume":"200","author":"Katakai","year":"2004","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.phrs.2017.04.006_bib0075","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nm0396-342","article-title":"Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture","volume":"2","author":"Renne","year":"1996","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.phrs.2017.04.006_bib0080","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S1535-6108(04)00082-0","article-title":"Phosphorylation of PML by mitogen-activated protein kinases plays a key role in arsenic trioxide-mediated apoptosis","volume":"5","author":"Hayakawa","year":"2004","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.phrs.2017.04.006_bib0085","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/leu.2011.249","article-title":"Targeting survivin and p53 in pediatric acute lymphoblastic leukemia","volume":"26","author":"Tyner","year":"2012","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.phrs.2017.04.006_bib0090","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1182\/blood-2012-05-427773","article-title":"Markedly additive antitumor activity with the combination of a selective survivin suppressant YM155 and alemtuzumab in adult T-cell leukemia","volume":"121","author":"Chen","year":"2013","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.phrs.2017.04.006_bib0095","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.bbrc.2013.04.036","article-title":"YM155 induces caspase-8 dependent apoptosis through downregulation of survivin and Mcl-1 in human leukemia cells","volume":"435","author":"Feng","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"17","key":"10.1016\/j.phrs.2017.04.006_bib0100","doi-asserted-by":"crossref","first-page":"8014","DOI":"10.1158\/0008-5472.CAN-07-1343","article-title":"YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts","volume":"67","author":"Nakahara","year":"2007","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.phrs.2017.04.006_bib0105","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.tcb.2013.07.006","article-title":"Evading apoptosis in cancer","volume":"23","author":"Fernald","year":"2013","journal-title":"Trends Cell Biol."},{"issue":"9","key":"10.1016\/j.phrs.2017.04.006_bib0110","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.bcp.2011.07.064","article-title":"Mcl-1 downregulation by YM155 contributes to its synergistic anti-tumor activities with ABT-263","volume":"82","author":"Tang","year":"2011","journal-title":"Biochem. Pharmacol."},{"issue":"3\u20134","key":"10.1016\/j.phrs.2017.04.006_bib0115","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0079-6107(98)00056-X","article-title":"MAP kinase pathways","volume":"71","author":"Cobb","year":"1999","journal-title":"Prog. Biophys. Mol. Biol."},{"issue":"7","key":"10.1016\/j.phrs.2017.04.006_bib0120","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1073\/pnas.94.7.3302","article-title":"Mitogen-activated protein kinase-mediated Fas apoptotic signaling pathway","volume":"94","author":"Goillot","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.phrs.2017.04.006_bib0125","first-page":"628","article-title":"Involvement of extracellular signal-regulated kinase 2 and stress-activated protein kinase\/Jun N-terminal kinase activation by transforming growth factor beta in the negative growth control of breast cancer cells","volume":"57","author":"Frey","year":"1997","journal-title":"Cancer Res."},{"issue":"14","key":"10.1016\/j.phrs.2017.04.006_bib0130","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1128\/MCB.00279-09","article-title":"Mcl-1 integrates the opposing actions of signaling pathways that mediate survival and apoptosis","volume":"29","author":"Morel","year":"2009","journal-title":"Mol. Cell. Biol."},{"issue":"2","key":"10.1016\/j.phrs.2017.04.006_bib0135","first-page":"202","article-title":"Survivin and YM155: how faithful is the liaison?","volume":"1845","author":"Rauch","year":"2014","journal-title":"Biochim. Biophys. Acta"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661817300427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661817300427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T01:24:47Z","timestamp":1601861087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661817300427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":27,"alternative-id":["S1043661817300427"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2017.04.006","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"YM155 induces apoptosis through proteasome-dependent degradation of MCL-1 in primary effusion lymphoma","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2017.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}